Search

everythinglearnresearchcommunity

for

Search:↓

The fractional carbon dioxide laser is a safe and effective treatment for alopecia areata and works better than betamethasone valerate cream alone.

Lasers and light therapies are effective in promoting hair regrowth for different types of hair loss.

Combining either fractional CO2 laser or microneedling with 5-FU is more effective for treating vitiligo.

FCO2 laser is a better treatment for alopecia areata than intralesional steroids.

Both cryotherapy and FCO2 laser are effective and safe for treating patchy alopecia areata.

Fractional CO2 laser is more effective and safer than steroid injections for treating alopecia areata.

Bimatoprost shows promise for treating vitiligo, especially when combined with other therapies.

Fractional CO2 laser therapy effectively improves skin conditions and recovery when combined with other treatments.

Combining laser with PRP is more effective for vitiligo than PRP alone.

Using a laser with bimatoprost solution works better for hair regrowth in alopecia areata than bimatoprost alone.

Combining fractional CO2 laser with minoxidil is more effective for hair growth in alopecia areata than minoxidil alone.

Light/laser therapy can effectively increase hair density in some types of alopecia, especially androgenic alopecia and alopecia areata.

Regenerative medicine is effective and safe for treating vitiligo.

Platelet-derived products help regenerate tissue and are used in various skin and hair treatments.

Several treatments are effective for pigmentary disorders like vitiligo and melasma.

Autologous platelet concentrates show promise in esthetic treatments but need more standardized research.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

Eye exams are crucial for kids with 13q deletion syndrome, tamoxifen can cause vision loss, Propecia may lead to cataracts, Lipoid Proteinosis causes skin bumps, and OCT is useful for diagnosing macular diseases.

A baby boy with 13q deletion syndrome had eye cancer, a woman's vision improved after stopping a breast cancer drug, a man developed cataracts from using Propecia, and a rare skin disorder called Lipoid Proteinosis was discussed. Also, a tool called OCT is useful for diagnosing macular diseases.

Taking Propecia might lead to the development of cataracts.

The document discusses various eye conditions and their treatments, including a rare eye cancer in a baby, vision loss from a cancer drug, cataracts from a baldness treatment, a rare skin disorder, and a specific type of eye disease diagnosed with a special imaging technique.

Finasteride, often used for hair loss, can potentially cause cataracts.

Most women with hirsutism have it because of PCOS, and they need long-term treatment including medication and hair removal to improve their condition.

The document concludes that careful diagnosis is crucial for chromosome 13q deletion syndrome, tamoxifen can cause reversible eye damage, finasteride may be linked to cataracts, and OCT is useful for diagnosing macular diseases.

Multiple eye conditions were studied, highlighting the importance of various imaging methods for diagnosis, the vision side effects of drugs tamoxifen and Propecia, and the usefulness of optical coherence tomography for diagnosing and monitoring macular and retinal diseases.

Hirsutism is often caused by high male hormone levels and can be treated with lifestyle changes and medications.

Eflornithine's effectiveness for women with facial hirsutism is unclear.

Targeted immunotherapy could be a promising new treatment for hair regrowth.